Posted by Michael Wonder on 29 Aug 2020
FDA announces Advisory Committee meeting to discuss COVID-19 vaccines
28 August 2020 - The U.S. Food and Drug Administration announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on 22 October 2020, to discuss the general matter of the development, authorisation, and/or licensure of vaccines indicated to prevent COVID-19.
The FDA intends to make background material available to the public, including the meeting agenda and Committee roster, no later than two business days before the meeting.
In general, advisory committees include a Chair, several members, plus a consumer, industry and sometimes a patient representative. Additional experts with special knowledge may be added for individual meetings as needed. Although the committees provide advice to the agency, final decisions are made by the FDA.
